TG Therapeutics (TGTX) Reports Q4 Loss of $0.48/Share

TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), versus ($0.37) reported last year.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
• Barclays says AI trade is maturing, favors greater diversification